Merck & Co., Inc.
MRK
$79.29
$1.171.50%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.61% | -6.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.61% | -6.20% | |||
| Cost of Revenue | -8.74% | -4.66% | |||
| Gross Profit | 1.92% | -6.67% | |||
| SG&A Expenses | -10.67% | 5.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.48% | -16.35% | |||
| Operating Income | 16.48% | 22.39% | |||
| Income Before Tax | 41.56% | 1.96% | |||
| Income Tax Expenses | 92.02% | -54.14% | |||
| Earnings from Continuing Operations | 35.82% | 18.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -500.00% | 75.00% | |||
| Net Income | 35.69% | 18.56% | |||
| EBIT | 16.48% | 22.39% | |||
| EBITDA | 12.77% | 17.15% | |||
| EPS Basic | 36.44% | 18.42% | |||
| Normalized Basic EPS | 19.87% | 14.58% | |||
| EPS Diluted | 36.23% | 18.98% | |||
| Normalized Diluted EPS | 19.49% | 14.90% | |||
| Average Basic Shares Outstanding | -0.55% | 0.12% | |||
| Average Diluted Shares Outstanding | -0.24% | -0.16% | |||
| Dividend Per Share | 5.19% | 0.00% | |||
| Payout Ratio | -0.23% | -0.16% | |||